What is Chardan Capital’s Estimate for EYPT FY2025 Earnings?
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 earnings per share estimates for EyePoint Pharmaceuticals in a research report issued on Monday, March 24th. Chardan Capital analyst D. Gataulin anticipates that the company will earn ($2.92) per share for the year. Chardan Capital currently has a […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 earnings per share estimates for EyePoint Pharmaceuticals in a research report issued on Monday, March 24th. Chardan Capital analyst D. Gataulin anticipates that the company will earn ($2.92) per share for the year. Chardan Capital currently has a […]
